|Description||PSB 0739 is a highly potent, direct‐acting and reversible P2Y12 receptor antagonist (Ki = 24.9 nM). Unlike clopidogrel, it does not require bioactivation. P2Y12 receptors regulate CFA‐induced hyperalgesia and the local inflammatory response, and platelet P2Y12 receptors contribute to these effects in the chronic inflammation phase.|
|Purity||≥95% by HPLC|
|Synonyms||1-Amino-9,10-dihydro-9,10-dioxo-4-[[4-(phenylamino)-3-sulfophenyl]amino]-2-anthracenesulfonic acid sodium salt; PSB-0739; PSB 0739; PSB0739 sodium|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
PIT selectively and non-competitively blocked P2Y1 receptor signaling without affecting nucleotide binding. PIT had no significant effect on agonist activation ...
MRS 4062 triethylammonium salt
MRS 4062 is a hP2Y4 agonist with EC50 value of 23 nM, EC50 value of 640 nM to P2Y2 receptor and EC50 value of 740 nM to P2Y6 receptor.
MRS 2365 is a highly potent, selective P2Y1 receptor agonist (EC50 = 0.4 nM), with no activity at P2Y12 receptors and only very low agonist activity at P2Y13 re...
Cangrelor tetrasodium is an ATP analogue and acts as a reversible antagonist of P2Y12 receptor. Pretreatment with cangrelor significantly reduces blood clotting...
Clopidogrel is converted to its active metabolite by cytochrome P450 (CYP) enzymes.
5-OMe-UDP trisodium salt
5-OMe-UDP trisodium salt is a P2Y6 agonist with EC50 value of 0.08 μM.
(±)-Clopidogrel hydrochloride is the hydrochloride salt of clopidogrel, which is a high affinity, selective and irreversible antagonist of the platelet purinerg...
AR-C126313, a thiouracil derivative, has been found to be a competitive P2Y2 receptor antagonist and could inhibit P2Y2 receptor-induced β-arrestin translocatio...